FindTrial
Sign In

Comparison of epidural analgesia with dexmedetomidine or sufentanil combined with ropivacaine: an observational study of multi-center

Comparison of epidural analgesia with dexmedetomidine or sufentanil combined with ropivacaine: an observational study of multi-center

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017124
Enrollment
Unknown
Registered
2018-07-12
Start date
2018-07-13
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

analgesia

Interventions

1:0.1 % ropivacaine + 0.5 µ g / ml dexmedetomidine
2:0.1 % ropivacaine + 0.5 µ g / ml sufentanil

Sponsors

International Peace Maternal and Child Health Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 42 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ASA1-2, age 20-35 years, gestational age of 37, weight 55 - 90kg, requiring labor analgesia.

Exclusion criteria

Exclusion criteria: The uterine cavity is more than 2cm, multiple fetuses, scar uterus, serious cardiovascular and cerebrovascular diseases, bradycardia, conduction block, fetal distress, spinal canal anesthesia contraindication.

Design outcomes

Primary

MeasureTime frame
Time of onset, maximum block level, analgesic effect, duration of labor;—

Countries

China

Contacts

Public ContactZeyong Yang

International Peace Maternal and Child Health Hospital, Shanghai Jiao Tong University School of Medicine

zeyongy2018@aliyun.com+86 13381827292

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026